Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

UNICEF and Rönesans Group Joined Forces to Support Children Affected by the Earthquakes in Turkiye

Published

on

unicef-and-ronesans-group-joined-forces-to-support-children-affected-by-the-earthquakes-in-turkiye

İSTANBUL, Türkiye, Oct. 4, 2023 /PRNewswire/ — In the wake of the devastating earthquakes that struck Gaziantep-Kahramanmaraş, Türkiye in February 2023, UNICEF partnered with Rönesans Group to provide essential services and support to children, adolescents and families impacted by the disaster. UNICEF and Rönesans have collaborated to set up Child, Adolescent, and Family Support Hubs (Birlikte) within the temporary living spaces constructed by Rönesans in Malatya, one of the eleven cities affected the most by the earthquakes in Türkiye, in order to protect children and ensure their mental health psychosocial well-being, and overall development.

 

 

Rönesans Holding, the conglomerate’s top investment entity, which is headquartered in Ankara, Türkiye, responded rapidly to the disaster, promptly constructing temporary living spaces in two cities in Türkiye, Malatya and Adıyaman. Carefully designed with the wellbeing of the most vulnerable members of society top of mind, especially women and children, these temporary living spaces have since become vital for those affected.

Since the 6th of February earthquakes, UNICEF has been working round the clock to provide services to children and families affected. Services provided by UNICEF have helped to ensure more than 405,600 children could return to formal and non-formal education and provided psychosocial support to over 862,000 children and carers. To date, UNICEF and its partners have established 53 child, adolescent, and family support hubs and spaces in the affected area.

During a recent joint field visit, Paolo Marchi, UNICEF Representative to Türkiye a.i. stated: “The earthquakes have profoundly affected and changed the lives of many children and left them with traumatic physical and psychological consequences. Rönesans Holding’s support enables us to extend psychosocial services in safe spaces to children, adolescents, and their caregivers. Such partnerships embody the spirit of solidarity and collective action. With Rönesans Holding, we aim to create a lasting impact on the lives of the affected children and their families.” 

In Malatya, UNICEF and Rönesans created centers for children, adolescents, and women including nurseries, a psychological counselling, sports & music centres for young people, social facilities, and study spaces. 

İpek Ilıcak Kayaalp, Chair of the Board of Directors of Rönesans, who was recently invited to the Business Advisory Board at UNICEF Turkiye, said: “We’re glad to be collaborating with UNICEF on this critical project, extending our help to those affected by the earthquake. Our goal is to ensure that the temporary living spaces prioritise the well-being of the most vulnerable segments of our society, with special attention paid to the needs of women, children, and youth. At Rönesans, our objective is to provide not only immediate relief but also to have a long-term impact that extends far beyond the initial response. We are committed to offering assistance and support for years to come in the aftermath of this tragedy, with far-reaching implications for the region and its population.”  

Aiming to create a sense of community and belonging for all residents, the temporary living spaces constructed and designed by Rönesans already serve over 10,000 people across Malatya and Adıyaman, serving as transitional structures to bridge the gap between immediate response and sustained support.  

Having worked with many other partners in the immediate aftermath of the earthquake, Rönesans also created safe zones and provided baby care rooms, playgrounds, special education support for children with disabilities and a children’s cinema. As well as focusing on emergency humanitarian aid during the earthquakes with an organised rapid response system that can respond quickly and effectively in times of need, Rönesans will continue to work together with UNICEF, supporting Birlikte Hubs within the temporary living spaces, and providing vital support to children and adolescent survivors of natural disasters. 

About Rönesans Group 

Rönesans Holding, the conglomerate’s top investment entity, headquartered in Ankara, is the 38th largest international contracting company globally and the 9th largest in Europe with international operations in 30 countries across Europe, Central Asia, the Middle East and Africa – including Ballast Nedam in the Netherlands and Heitkamp in Germany, Rönesans has been operating as the main contractor and investor successfully for 30 years across construction, real estate development, healthcare and energy. Putting resilience and growth through innovation at the core of the company, with a priority on sustainability and social development, Rönesans has developed projects supporting students with scholarships, academic platforms and initiatives; been a signatory of the UN Global Compact since 2015; and a signatory of the UN Women’s Empowerment Principles since 2016. 

Along with its partners GIC, Meridiam Infrastructure, Sojitz, Samsung C&T, TotalEnergies, and IFC, of the World Bank Group (minority shareholder in the group), Rönesans has invested more than EUR7 billion into pioneering projects in Türkiye.  

About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. 
For more information about UNICEF and its work, visit: www.unicef.org

Follow UNICEF on Twitter, Facebook, Instagram and YouTube

Photo – https://mma.prnewswire.com/media/2237797/Ronesans_Holding_1.jpg
Photo – https://mma.prnewswire.com/media/2237798/Ronesans_Holding_2.jpg
Photo – https://mma.prnewswire.com/media/2237799/Ronesans_Holding_3.jpg
Logo – https://mma.prnewswire.com/media/2213961/ronesans_holding_Logo.jpg

 

İpek Ilıcak Kayaalp , Chair of the Board of Directors of Rönesans, and Paolo Marchi, UNICEF Türkiye Representative, met with children and young individuals at Malatya Yaşam Kent.

 

İpek Ilıcak Kayaalp , Chair of the Board of Directors of Rönesans, and Paolo Marchi, UNICEF Türkiye Representative, met with children and young individuals at Malatya Yaşam Kent.

 

Rönesans Holding Logo

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/unicef-and-ronesans-group-joined-forces-to-support-children-affected-by-the-earthquakes-in-turkiye-301946145.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending